HighQC™ Human IPSC From Fibroblast-Long QT Syndrome 2
HighQC™ Human iPSC derived from fibroblasts with Long QT Syndrome 2 mutations, ideal for heart disease modeling and drug testing applications.
本分类收录的细胞产品与配套技术资料,支持按来源、物种与规格筛选。 共 293 个产品。
HighQC™ Human iPSC derived from fibroblasts with Long QT Syndrome 2 mutations, ideal for heart disease modeling and drug testing applications.
Utilize HighQC™ Human IPSC From Fibroblast-Long QT Syndrome 3 for cardiac electrophysiology research, arrhythmia modeling, and drug safety evaluation.
HighQC™ Human IPSC From Fibroblast-Miller-Dieker Lissencephaly Syndrome, HighQC™ hiPSC MDS, hiPSC-MDS, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Miller-Dieker Lissencephaly Syndrome
Monocarboxylate Transporter 8-Specific Thyroid Hormone Cell Transporter Deficiency
Monocarboxylate Transporter 9-Specific Thyroid Hormone Cell Transporter Deficiency
Cell Type: iPSC; Disease: Muscular Dystrophy, Duchenne Type; DMD DYSTROPHIN; DMD.
HighQC™ Human IPSCs From Fibroblasts-Niemann-Pick Disease, Type C1 are a disease-specific induced pluripotent stem cell line generated from human dermal fibroblasts carrying pathogenic alterations in the Niemann-Pick disease type C1 gene, a key regulator of intracellular cholesterol and lipid trafficking associated with Niemann-Pick disease type C1, a hereditary lysosomal storage disorder. The parental fibroblasts are reprogrammed into a pluripotent state using Sendai virus–mediated delivery of defined transcription factors. These iPSCs exhibit pluripotency, with the ability to differentiate into all three germ layers under defined conditions, and express the pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ human iPSCs from fibroblasts model phenylketonuria, helping research genetic mechanisms and therapies for metabolic disorders and gene editing.
Cell Type: iPSC; Disease: Pitt-Hopkins Syndrome; PTHS TRANSCRIPTION FACTOR 4; TCF4.
Leverage HighQC™ Human IPSC From Fibroblast-Skeletal Displasia to model skeletal abnormalities and test candidate drugs in personalized systems.
HighQC™ Human IPSC From Fibroblast-Spinal Muscular Atrophy, TYPE II is a disease-specific induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Spinal Muscular Atrophy (SMA) Type II, an autosomal recessive disorder caused by mutations in the SMN1 gene. These cells exhibit adherent growth and maintain the capacity for trilineage differentiation into ectoderm, mesoderm, and endoderm derivatives under appropriate conditions. These iPSCs (induced pluripotent stem cells) express the core pluripotency marker SSEA-4. They preserve SMA-related physiology and enable motor neuron function study. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
Discover HighQC™ Human iPSC derived from fibroblasts for sporadic Alzheimer’s disease research. Enhance your studies with our reliable cell models.
HighQC™ Human IPSC From Fibroblast-Tuberous Sclerosis 2 is a disease-specific human induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Tuberous Sclerosis Complex (TSC) Type 2, an autosomal dominant disorder caused by mutations in the TSC2 gene. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They sustain pluripotency and reflect TSC2-related physiological traits. These cells retain the fundamental capacity for trilineage differentiation into ectoderm, mesoderm, and endoderm derivatives under directed conditions. They express core pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From Fibroblast-Vici Syndrome offers an iPSC model for autophagy, neurodevelopment, and disease mechanism studies. In vitro models.
HighQC™ Human IPSC From Fibroblast-Werner Syndrome provides a disease-relevant iPSC model for studying WRN-linked premature aging and genetic disorders.
HighQC™ Human IPSC From Fibroblast-Wolman Disease supports lipid-storage disorder modeling ideal for pathogenesis and therapeutic investigation.
HighQC™ Human IPSC From Fibroblast (Mucopolysaccharidosis Type IIIA) supports disease modeling, enzyme deficiency research, and SGSH-related iPSC studies.
HighQC™ Human IPSC With Niemann Pick Type C Mutation provides a disease-specific stem cell model for NPC1-related pathogenesis and therapy development.
Explore HighQC™ Human IPSC From Foreskin Fibroblast (Alzheimer’s Disease Patient, PSEN2, N141I) for neurodegeneration modeling and PSEN2 mutation studies.
HighQC™ Human IPSC From Foreskin Fibroblast supports stem cell differentiation, genetic stability evaluation, and reprogramming from amniotic MSC origin.
Deploy HighQC™ Human IPSC From Foreskin Fibroblast (Fibroblasts Of A Cystic Fibrosis Patient) to model CFTR dysfunction and test therapeutic agents.
iPSC (induced Pluripotent Stem cells) reprogrammed from human Foreskin Fibroblasts
Leverage HighQC™ Human IPSC From Foreskin Fibroblast (Morbus Niemann Pick Type C) to study NPC pathogenesis and evaluate potential therapeutic strategies.
iPSC (induced Pluripotent Stem cells) reprogrammed from human Multipotent Stem Cells.
共 293 个产品 | 第 5 / 13 页